This Book >>

  • 348pp. Published June 2017
  • Scientific Research Publishing, Inc.,USA.
  • Category: Biomedical & Life Sciences
  • ISBN: 978-1-61896-328-4
  • (Hardcover) USD 109.00
  • ISBN: 978-1-61896-327-7
  • (Paperback) USD 89.00
Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org

Connect with SCIRP >>

Home > Books > Advances in Inflammatory Bowel Disease
Advances in Inflammatory Bowel Disease
  • Description
  • Author(s) Information

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. The chief types of inflammatory bowel disease are Crohn’s disease and ulcerative colitis (UC). Inflammatory bowel diseases fall into the class of autoimmune diseases, in which the body’s own immune system attacks elements of the digestive system.  It is important to note that not only does Crohn’s disease affect the small intestine and large intestine, it can also affect the mouth, esophagus, stomach and the anus whereas ulcerative colitis primarily affects the colon and the rectum. IBD resulted in a global total of 51,000 deaths in 2013 and 55,000 deaths in 1990. The increased incidence of IBD since World War 2 has been linked to the increase in meat consumption worldwide, supporting the claim that animal protein intake is associated with IBD. Inflammatory bowel diseases are increasing in Europe.


In the present book, fifteen typical literatures about inflammatory bowel disease published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, autoimmune diseases, inflammatory disease, epidemiology, ect. We hope this book can demonstrate advances in inflammatory bowel disease as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Inflammatory Bowel Disease as a Disorder of an Imbalance between Pro- and Anti-inflammatory Molecules and Deficiency of Resolution Bioactive Lipids
  • Chapter 2
    Endoscopic Disease Activity in Inflammatory Bowel Disease
  • Chapter 3
    Molecular Mimicry, Inflammatory Bowel Disease, and the Vaccine Safety Debate
  • Chapter 4
    Increasing Rate of Inflammatory Bowel Disease: A 12-Year Retrospective Study in NingXia, China
  • Chapter 5
    Inflammatory Bowel Disease (IBD)-Like Disease in a Case of a 33-Year Old Man with Glycogenosis 1b
  • Chapter 6
    Prevalence of Inflammatory Bowel Disease among Coeliac Disease Patients in a Hungarian Coeliac Centre
  • Chapter 7
    Anti-Outer Membrane Protein C and Anti-Glycoprotein 2 Antibodies in Inflammatory Bowel Disease and Their Association with Complicated Forms of Crohn’s Disease
  • Chapter 8
    Fecal Lactoferrin in Discriminating Inflammatory Bowel Disease from Irritable Bowel Syndrome: A Diagnostic Meta-Analysis
  • Chapter 9
    Sleep Disturbances in Japanese Patients with Inflammatory Bowel Disease and Their Impact on Disease Flare
  • Chapter 10
    Ultrasound in Children and Adolescents with Inflammatory Bowel Disease
  • Chapter 11
    Cognitive-Behavioural Therapy Has No Effect on Disease Activity but Improves Quality of Life in Subgroups of Patients with Inflammatory Bowel Disease: A Pilot Randomised Controlled Trial
  • Chapter 12
    Inflammatory Bowel Diseases (Crohn’s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
  • Chapter 13
    Experiences of Healing Therapy in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease
  • Chapter 14
    An Anti-Inflammatory Diet as Treatment for Inflammatory Bowel Disease: A Case Series Report
  • Chapter 15
    Effectiveness and Safety of Ferric Carboxymaltose Treatment in Children and Adolescents with Inflammatory Bowel Disease and Other Gastrointestinal Diseases
Readership: Students, academics, teachers and other people attending or interested in Inflammatory Bowel Disease.
comments powered by Disqus